Notice - Prescription Drug List (PDL): Lovastatin (English, HTML)
Notice - Prescription Drug List (PDL): Lovastatin: English HTML file. From Health Canada, updated Sep 2023. View metadata, licence and the direct download on CanQuery.
- Format
- HTML
- Access
- Original download only
- Publisher-reported update
- 2023-09-29
The purpose of this Notice of Amendment is to announce the revised listing for lovastatin on the Prescription Drug List (PDL). As stated in the Notice of Intent to Amend, posted June 4, 2014, the revision will allow lovastatin to be marketed as a nonprescription product. Only the Human part of the PDL has been revised.
Data overview
- Formats
- HTML
- File languages
- English
- Available actions
- Access original file